BackX.T.L. Biopharmaceuticals Overview

X.T.L. Biopharmaceuticals Profit Margin

Profitability ratio analysis for XTLB.

Quarterly Profit Margin

-88.24%

As of Dec 2024

Annual Profit Margin (TTM)

-227.72%

Trailing 12 months ending Dec 2024

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin